Louisiana HB920 mandates drug manufacturers to limit the cost of GLP-1 medications for health insurance plans.
Louisiana HB920 requires drug manufacturers to limit the pricing of GLP-1 medications for health insurance plans, ensuring that insured individuals do not pay more than $200 for a 30-day supply. The bill extends GLP-1 medication coverage to Medicaid, the Office of Group Benefits, and other health plans, regardless of the insured's medical condition or diagnosis. The Louisiana Department of Health may seek federal Medicaid waivers and state plan amendments to implement these provisions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.